It was always going to be a standalone test. Albertsons spent most of the past two years preparing to hand itself to Kroger in a roughly $25 billion deal, only to have the transaction blocked by federal courts and terminated in December 2024. This first quarter of fiscal 2026 is the clearest look yet at the company it now must be on its own: a 2,240-store, 22-banner grocer with a leveraged balance sheet, a value-conscious customer, and no acquirer to rescue the arithmetic. The quarter's headline is a milestone the company has not wanted to report - identical sales, excluding fuel, fell 0.8% year over year, the first negative print after a string of positive years, on the widest industry demand pressure the management team says it has seen in its recent history. Wall Street punished the admission: the stock lost roughly a fifth of its value in a single session when results and a lowered outlook were released on July 23.
The two ways to read the quarter are a dilution problem and a correction. On the first reading, adjusted earnings per share of $0.42 fell from $0.55 a year ago, adjusted EBITDA fell to $1.01 billion from $1.11 billion, and management cut its full-year guidance - adjusted EBITDA to $3.55 billion to $3.625 billion, adjusted EPS to $1.75 to $1.85, identical sales to a range of negative 0.5% to negative 1.5%. On the second reading, the company is treating the miss not as a capitulation but as the trigger for its most consequential standalone move: ACI Edge, a restructuring that collapses 11 divisions into four regions, centralizes center-store merchandising, and is expected to unlock about $200 million of annual benefits by fiscal 2027, most of it earmarked for reinvestment in price. On the same call, the company announced its President and CFO, Sharon McCollam, is retiring, with a successor search underway.
What decides the thesis is straightforward: can a mid-priced, high-low promotional grocer with roughly $8.9 billion of net debt win back negative identical sales against Walmart, Amazon, and Aldi by reinvesting in price - before the stock's optically cheap multiple turns out to be a value trap rather than a value? The stock now trades at roughly 6.8x forward adjusted earnings and about 4x trailing adjusted EBITDA against peers trading at a premium and at a discount alike. That is not a price the market has agreed to pay for growth; it is a price the market is charging for proof. The answer to the central question should come quickly - management guides identical sales to improve only modestly through the back half, so the next two quarters largely settle whether the standalone model holds the line or erodes.